Thomas Arnesen Selected Research

protein N-terminal acetyltransferase

11/2021	Missense NAA20 variants impairing the NatB protein N-terminal acetyltransferase cause autosomal recessive developmental delay, intellectual disability, and microcephaly.
3/2012	Human protein N-terminal acetyltransferase hNaa50p (hNAT5/hSAN) follows ordered sequential catalytic mechanism: combined kinetic and NMR study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Arnesen Research Topics

Disease

8	Neoplasms (Cancer) 01/2015 - 10/2005
4	Intellectual Disability (Idiocy) 11/2021 - 11/2015
4	Adenoma (Adenomas) 01/2021 - 08/2013
4	Inborn Genetic Diseases (Disease, Hereditary) 04/2015 - 07/2011
3	Microcephaly 11/2021 - 01/2016
3	Hypoxia (Hypoxemia) 11/2005 - 03/2005
2	Hereditary Sensory and Autonomic Neuropathies (HSAN) 03/2012 - 04/2006
2	Thyroid Neoplasms (Thyroid Cancer) 12/2010 - 10/2005
2	Carcinogenesis 10/2005 - 03/2005
1	Type 3 Maturity-Onset Diabetes of the Young 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Hyperaldosteronism (Conn Syndrome) 01/2021
1	Congenital Hyperinsulinism 01/2021
1	Familial Hyperaldosteronism 11/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Starvation 12/2018
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018
1	Neurodevelopmental Disorders 01/2018
1	Separation Anxiety (Separation Anxiety Disorder) 12/2016
1	Hyperplasia 08/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2009
1	Lung Neoplasms (Lung Cancer) 11/2008
1	Melanoma (Melanoma, Malignant) 12/2006
1	Papillary Thyroid Cancer 10/2005
1	Papillary Carcinoma 10/2005
1	Glioma (Gliomas) 03/2005

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2005
6	N-acetyltryptophanamide (NATA)IBA 12/2018 - 04/2006
6	N-Terminal AcetyltransferasesIBA 12/2016 - 04/2006
5	AcetyltransferasesIBA 01/2019 - 03/2005
4	AldosteroneIBA 01/2021 - 08/2013
4	N-acetyltalosaminuronic acid (NAT)IBA 04/2015 - 03/2005
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 03/2005
3	Pharmaceutical PreparationsIBA 01/2013 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2013
2	protein N-terminal acetyltransferaseIBA 11/2021 - 03/2012
1	Glutamate DehydrogenaseIBA 01/2021
1	Chloride Channels (Chloride Channel)IBA 11/2019
1	SynucleinsIBA 01/2019
1	GlycogenIBA 12/2018
1	ChromatinIBA 01/2015
1	EnzymesIBA 10/2011
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2010
1	Troglitazone (Rezulin)FDA Link 12/2010
1	RacivirIBA 12/2010
1	Fluorouracil (Carac)FDA LinkGeneric 09/2009
1	Cyclin D1IBA 11/2008
1	beta CateninIBA 11/2008
1	Biological ProductsIBA 10/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2006
1	Messenger RNA (mRNA)IBA 10/2005
1	TransferasesIBA 10/2005
1	AntibodiesIBA 10/2005